Another major target, vascular endothelial growth factor receptor 2 (VEGFR2), is a key mediator of tumor angiogenesis, the process by which cancer cells stimulate new blood vessel formation to ensure an adequate supply of oxygen and nutrients36–40. The gene discussed is KDR; the disease is neoplasm.